Clinical Trial

State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

Study acronym: STARLIGHT
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-14.
Trial Details
NCT Number NCT06888128
Lead Sponsor Baylor College of Medicine
Collaborators: Texas Department of State Health Services, Usona Institute, AIM Youth Mental Health
Conditions PTSD
Enrollment 15 participants
Start Date 2025-01-30
Primary Completion 2026-12-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-22